gsao
Small moleculeexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2008 (NCT01147029)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- ADP/ATP translocase 1INHIBITOR
inhibitor - SLC25A4
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- gsao
- gsao
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01147029 | Phase 1 | Jan 1, 2008 | Cancer Research UK, The Christie NHS Foundation Trust |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Cancer Research UK | Academic/Hospital | 1 | 1 | 1 | 2008 |
| The Christie NHS Foundation Trust | Academic/Hospital | 1 | 0 | 1 | 2008 |
2 organizations
Page 1 / 1